- Home
- COYA vs CHMI Comparison
COYA vs CHMI Comparison
Compare COYA & CHMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COYA
- CHMI
- Stock Information
- Founded
- COYA 2020
- CHMI 2012
- Country
- COYA United States
- CHMI United States
- Employees
- COYA N/A
- CHMI N/A
- Industry
- COYA Biotechnology: Pharmaceutical Preparations
- CHMI Real Estate Investment Trusts
- Sector
- COYA Health Care
- CHMI Real Estate
- Exchange
- COYA Nasdaq
- CHMI Nasdaq
- Market Cap
- COYA 98.5M
- CHMI 92.0M
- IPO Year
- COYA 2022
- CHMI 2013
- Fundamental
- Price
- COYA $6.48
- CHMI $3.50
- Analyst Decision
- COYA Strong Buy
- CHMI Buy
- Analyst Count
- COYA 4
- CHMI 3
- Target Price
- COYA $16.25
- CHMI $5.00
- AVG Volume (30 Days)
- COYA 143.6K
- CHMI 257.5K
- Earning Date
- COYA 05-08-2025
- CHMI 03-06-2025
- Dividend Yield
- COYA N/A
- CHMI 17.34%
- EPS Growth
- COYA N/A
- CHMI N/A
- EPS
- COYA N/A
- CHMI 0.07
- Revenue
- COYA $9,554,315.00
- CHMI $46,993,000.00
- Revenue This Year
- COYA N/A
- CHMI N/A
- Revenue Next Year
- COYA $56.22
- CHMI $27.78
- P/E Ratio
- COYA N/A
- CHMI $54.36
- Revenue Growth
- COYA N/A
- CHMI N/A
- 52 Week Low
- COYA $4.75
- CHMI $2.50
- 52 Week High
- COYA $10.69
- CHMI $3.99
- Technical
- Relative Strength Index (RSI)
- COYA 49.74
- CHMI 54.97
- Support Level
- COYA $6.21
- CHMI $3.34
- Resistance Level
- COYA $6.96
- CHMI $3.60
- Average True Range (ATR)
- COYA 0.69
- CHMI 0.11
- MACD
- COYA -0.03
- CHMI -0.03
- Stochastic Oscillator
- COYA 27.16
- CHMI 48.57
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
About CHMI Cherry Hill Mortgage Investment Corporation
Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.